180 related articles for article (PubMed ID: 8821739)
21. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS; Gyte AJ; Upton R; Wyatt I
Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
[TBL] [Abstract][Full Text] [Related]
22. Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures.
Tomczyk T; Haberek G; Zuchora B; Jarosławska-Zych A; Kowalczyk MS; Wielosz M; Urbańska EM
Pharmacol Rep; 2007; 59(4):462-6. PubMed ID: 17901576
[TBL] [Abstract][Full Text] [Related]
23. Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist.
Domenici MR; Sagratella S; Ongini E; Longo R; Scotti de Carolis A
Eur J Pharmacol; 1994 Dec; 271(2-3):259-63. PubMed ID: 7705426
[TBL] [Abstract][Full Text] [Related]
24. Estimation of the relative potency of two glycine antagonists on NMDA-induced depolarizations in BRSC and ARCS.
Corsi M; Bettelini L; Fina P; Trist DG
Ann N Y Acad Sci; 1997 May; 812():187-8. PubMed ID: 9186738
[No Abstract] [Full Text] [Related]
25. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
Rho JM; Donevan SD; Rogawski MA
Ann Neurol; 1994 Feb; 35(2):229-34. PubMed ID: 8109904
[TBL] [Abstract][Full Text] [Related]
27. Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons.
Fontana G; Valenti L; Raiteri M
J Neurosci Res; 1997 Sep; 49(6):732-8. PubMed ID: 9335260
[TBL] [Abstract][Full Text] [Related]
28. Glycine-induced CA1 excitotoxicity in the rat hippocampal slice.
Wallis RA; Panizzon KL; Nolan JP
Brain Res; 1994 Nov; 664(1-2):115-25. PubMed ID: 7895020
[TBL] [Abstract][Full Text] [Related]
29. Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones.
Wang LY; MacDonald JF
J Physiol; 1995 Jul; 486 ( Pt 1)(Pt 1):83-95. PubMed ID: 7562646
[TBL] [Abstract][Full Text] [Related]
30. Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.
Boje KM; Wong G; Skolnick P
Brain Res; 1993 Feb; 603(2):207-14. PubMed ID: 8096423
[TBL] [Abstract][Full Text] [Related]
31. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain.
Ali C; Nicole O; Docagne F; Lesne S; MacKenzie ET; Nouvelot A; Buisson A; Vivien D
J Cereb Blood Flow Metab; 2000 Jun; 20(6):956-66. PubMed ID: 10894179
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
33. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization.
Chen Q; Surmeier DJ; Reiner A
Exp Neurol; 1999 Sep; 159(1):283-96. PubMed ID: 10486197
[TBL] [Abstract][Full Text] [Related]
34. CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) antagonizes NMDA-evoked [3H]GABA release from cultured cortical neurons via an inhibitory action at the strychnine-insensitive glycine site.
Harris KM; Miller RJ
Brain Res; 1989 Jun; 489(1):185-9. PubMed ID: 2568152
[TBL] [Abstract][Full Text] [Related]
35. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor".
Rogawski MA; Wasterlain CG; Mazarati AM
Epilepsia; 2000 Jul; 41(7):918-9. PubMed ID: 10897169
[No Abstract] [Full Text] [Related]
36. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
O'Leary DM; Movsesyan V; Vicini S; Faden AI
Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
[TBL] [Abstract][Full Text] [Related]
37. Na+,K+-ATPase functionally interacts with the plasma membrane Na+,Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress.
Sibarov DA; Bolshakov AE; Abushik PA; Krivoi II; Antonov SM
J Pharmacol Exp Ther; 2012 Dec; 343(3):596-607. PubMed ID: 22927545
[TBL] [Abstract][Full Text] [Related]
38. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
[TBL] [Abstract][Full Text] [Related]
39. Effects of various nitric oxide synthase inhibitors on NMDA-induced neuronal injury in rat cortical neurons.
Wang JY; Chi SI; Wang JY; Hwang CP; Wang JY
Chin J Physiol; 1996; 39(4):227-33. PubMed ID: 9058007
[TBL] [Abstract][Full Text] [Related]
40. 2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as selective glycine antagonist with in vivo activity.
Micheli F; Cugola A; Donati D; Missio A; Pecunioso A; Reggiani A; Tarzia G
Bioorg Med Chem; 1997 Dec; 5(12):2129-32. PubMed ID: 9459010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
